Bendamustine Plus Rituximab Is an Effective First-Line Treatment in Hairy Cell Leukemia Variant: A Report of Three Cases
Oncotarget - United States
doi 10.18632/oncotarget.21304
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 28, 2017
Authors
Publisher
Impact Journals, LLC